Califf gets precise
How Califf sees FDA's role in the Precision Medicine Initiative
During a fireside chat with FDA Commissioner Robert Califf at the BIO International Convention, BioCentury asked about FDA's role in the Precision Medicine Initiative. For the record, our question and his answer follow.
BioCentury: FDA has a big role in making the Precision Medicine Initiative happen. One of the elements is next-generation sequencing. That's something you've personally worked on a lot. What are your thoughts about the regulatory environment for NGS, why are you devoting a lot of time to it, and why is it important?
Robert Califf: One reason I'm devoting time to it is the president personally told me to do it. One thing I've learned in Washington is if the